Skip to content Skip to footer

Hepatoprotective Job of Natural Medication ‘Livobetter and Immunorm Cases’ in Hepatitis C


Dr. Harish Verma, B.A.M.S. (Gold Medalist, Master Nanak Dev College, Amritsar)
Owner of Ayurvedic Assembling Organization, Indian Natural Cures



Hepatitis C is turning into a significant medical issue of north India, which represents one-fourth of all instances of ongoing liver illnesses in the district and public concern is heightening.

Until the mid-1990s, Interferon was the main accessible treatment in current medication. The expansion of Ribavirin, a nucleoside simple, significantly worked on the reaction; in any case, viral genotype stays a significant determinant of reaction rate. It appears to be that interferon treatment alone or in blend might forestall movement of hepatic fibrosis in tainted patients regardless of whether fix isn’t accomplished. Despite the fact that Ribavirin alone doesn’t appear to be dynamic against HCV, the blend brought about significantly better and supported biochemical, virological and histological reaction rates.

Late examinations have shown that long-acting pegylated interferon (changed type of interferon) have preferable viral reaction over standard INF-an arrangements and in blend with Ribavirin, accomplished supported viral destruction paces of 54-56% In India, the level of supported responders is very high (50-60%). Such reaction of INF-a treatment in ongoing hepatitis C is because of a dominating pervasiveness of hepatitis C genotype 3 around here, which is interferon touchy.

Sadly, backslide happens in the greater part of these situations when treatment is halted. No other therapy choice was accessible for patients with persistent hepatitis C – hence, in spite of these humble reactions, both interferon and ribavirin are costly as well as make serious side impacts. Interferon-based treatment is particularly tricky in patients with mental problems like misery. As a matter of fact, a past filled with serious misery or other mental circumstances is viewed as a moderately solid contraindication to interferon-based treatment, since portion reliant and reversible neuro – mental impact happens in 30 to 40% of patients during treatment.

Scope of Alternative Medicine

Subsequently, there is a need to investigate the extent of practical regular items with negligible secondary effects in the therapy of persistent hepatitis C.

In Ayurvedic texts following spices are generally suggested for patients experiencing Persistent Liver Issues:

Andrographis paniculata, Raphanus sativus, Achyranthes aspera, Curcuma longa, Glycyrrhiza glabra, Rheum emodi, Cichorium intybus, Tinospora cordifolia, Aloe vera, Berberis aristata, Boerhavia diffusa, Eclipta alba, Solanum nigrum, Emblica officinalis, Ocimum sanctum, Terminalia chebula and Terminalia arjuna.

Preliminary work done by Dr Harish Verma (BAMS)

Based on following major pharmacological activities of spices from previously mentioned bunch:


Immuno Modulator

The observation was initiated with a view to find out:

Whether Livobetter Cases and Immunorm Containers can standardize the raised serum alanine aminotransferase (ALT) catalysts in HCV patients.

Whether Livobetter Cases and Immunorm Containers can help in decreasing the ‘Viral Burden’ in the blood

Whether repeat, which is normal element, can be forestalled by Livobetter Cases and Immunorm Containers

Our observation on approx. 500 patients of positive anti – HCV antibodies confirmed that HCV Compounds :
  • Livobetter Cases and Immunorm Containers were all around endured by all patients.
  • Patients with history of repeat or backslide after Interferon and Ribavirin Treatment were given just Livobetter Containers and Immunorm Cases.
  • Infection Burden was essentially diminished in HCV Genotype 1 cases.
  • Infection Burden was decreased minutely in HCV Genotype 3 and 4 situations when Livobetter Cases and Immunorm Containers were given alone.
  • Infection Burden was decreased surprisingly in HCV Genotype 3 and 4 situations when Livobetter Containers and Immunorm Cases were given alongside Interferon and Ribavirin Treatment.
  • Livobetter Cases and Immunorm Containers Standardize raised Liver Compounds inside 4 to about two months in all Genotypes.
  • In the subsequent time of two years a couple of patients revealed backslides.


In a non-industrial nation like India the expense of mixed treatment of Interferon and Ribavirin for persistent hepatitis C treatment is around Rs 5-10 lakhs. Since a greater part of the populace isn’t covered by health care coverage, monetary requirements become a significant snag for some patients to start treatment. Our Ayurveda based home grown compounds have shown promising outcomes in hepatitis C treatment. Appropriate assessment of these homegrown arrangements for treatment of Hepatitis C requires prompt consideration. In the event that further exploration will be done on these mixtures, there is a possibility of fostering the savvy regular items with negligible secondary effects in the therapy of persistent hepatitis C.